当前位置:首页 - 行情中心 - 永顺生物(839729) - 财务分析

永顺生物

(839729)

  

流通市值:5.06亿  总市值:17.22亿
流通股本:8024.46万   总股本:2.73亿

永顺生物(839729)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.08亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益67692.47万元,未分配利润14488.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产80186.60万元,负债12494.13万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入66,495,478.87314,282,861.48252,920,068.67152,714,720.89
营业总成本57,569,882.86258,618,527.57198,400,377.18117,364,146.85
营业利润9,360,944.9961,103,036.7161,427,887.8440,910,248.78
利润总额9,420,501.365,280,847.3165,597,008.1445,397,776.89
净利润8,374,511.5158,058,744.2557,737,233.3739,790,645.55
其他综合收益----
综合收益总额8,374,511.5158,058,744.2557,737,233.3739,790,645.55
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计584,482,912.07563,546,980.74613,010,371.44581,132,813.12
非流动资产合计217,383,096.16224,312,983.97229,544,063.37236,218,909.43
资产总计801,866,008.23787,859,964.71842,554,434.81817,351,722.55
流动负债合计114,482,878.12108,233,580.73162,524,484.69153,949,212.77
非流动负债合计10,458,453.2811,076,218.6611,812,155.2212,962,489.23
负债合计124,941,331.4119,309,799.39174,336,639.91166,911,702
归属于母公司股东权益合计676,924,676.83668,550,165.32668,217,794.9650,440,020.55
股东权益合计676,924,676.83668,550,165.32668,217,794.9650,440,020.55
负债和股东权益合计801,866,008.23787,859,964.71842,554,434.81817,351,722.55
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计67,850,571.06301,506,983.21215,074,130.05142,622,765.69
经营活动现金流出小计51,340,444.49270,445,109.18202,800,724.66137,426,795.41
经营活动产生的现金流量净额16,510,126.5731,061,874.0312,273,405.395,195,970.28
投资活动现金流入小计46,599,181.42134,513,963.2184,103,841.0851,972,952.6
投资活动现金流出小计31,004,727213,738,460.14103,184,590.36102,609,099.5
投资活动产生的现金流量净额15,594,454.42-79,224,496.93-19,080,749.28-50,636,146.9
筹资活动现金流入小计12,785,666.0568,298,135.244,911,22835,100,000
筹资活动现金流出小计274,771.73152,764,358.9587,407,728.0386,668,847.66
筹资活动产生的现金流量净额12,510,894.32-84,466,223.75-42,496,500.03-51,568,847.66
汇率变动对现金及现金等价物的影响14,490.42-96,065.23107,081.79123,136.17
现金及现金等价物净增加额44,629,965.73-132,724,911.88-49,196,762.13-96,885,888.11
期末现金及现金等价物余额205,772,155.39161,142,189.66244,670,339.41196,981,213.43
TOP↑